Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference
Author Information
Author(s): Fulton Amy, Peters Sarah T., Perkins Gillian A., Jarosinski Keith W., Damiani Armando, Brosnahan Margaret, Buckles Elizabeth L., Osterrieder Nikolaus, Van de Walle Gerlinde R.
Primary Institution: Cornell University
Hypothesis
Can small interfering RNAs (siRNAs) effectively reduce equine herpesvirus type 1 (EHV-1) infection in vitro and in vivo?
Conclusion
siRNA treatment has potential for both prevention and early treatment of EHV-1 infections.
Supporting Evidence
- siRNA therapy significantly reduced virus production and plaque size in vitro.
- Viral titers were reduced 80-fold with a single siRNA or with lower doses when used in combination.
- siRNA treatment in vivo significantly reduced viral replication and clinical signs in a mouse model.
- Intranasal treatment was effective when given up to 12 hours before or after infection.
Takeaway
Scientists found that a special type of medicine called siRNA can help stop a virus that makes horses sick, even after they get infected.
Methodology
The study used siRNA therapy in vitro and in a murine model to evaluate its effectiveness against EHV-1.
Limitations
The study was conducted in a mouse model, which may not fully replicate the disease in horses.
Participant Demographics
Mice were used in the study, specifically BALB/c mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website